Muscat: The General Directorate of Pharmacy and Drug Control of the Ministry of Health has issued a circular suspending the registration, importation and distribution of all medicines containing ranitidine.
The decision initiated by the Central Gulf Committee for Drug Registration is based on the recommendations of the US Food and Drug Administration, FDA.
The Ministry called on patients wishing to stop taking ranitidine, to consult a healthcare professional for replacement.
Read More
- Oman lays foundation stone for genome centre costing more than RO 4.2 million
- Nearly 60% of high blood pressure cases go undiagnosed, Oxford study finds
- ADHD: An emerging discussion on a shared disorder
- Matcha Mania: Is the green drink really as healthy as it seems?
- Oman marks World Health Day, highlights commitment to health innovation and digital transformation
